company background image
300452 logo

Anhui Sunhere Pharmaceutical ExcipientsLtd SZSE:300452 Stock Report

Last Price

CN¥12.48

Market Cap

CN¥2.9b

7D

-2.5%

1Y

-8.8%

Updated

24 Dec, 2024

Data

Company Financials +

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.

SZSE:300452 Stock Report

Market Cap: CN¥2.9b

300452 Stock Overview

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. More details

300452 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance3/6
Financial Health5/6
Dividends3/6

Rewards

Price-To-Earnings ratio (18.1x) is below the CN market (35.5x)

Earnings are forecast to grow 18.14% per year

Earnings grew by 0.5% over the past year

Trading at good value compared to peers and industry

Risk Analysis

No risks detected for 300452 from our risk checks.

My Notes

Capture your thoughts, links and company narrative

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Competitors

Jiangsu Lianhuan Pharmaceutical

SHSE:600513

CN¥3.0b

Henan Taloph Pharmaceutical StockLtd

SHSE:600222

CN¥2.8b

ChengDu ShengNuo BiotecLtd

SHSE:688117

CN¥3.0b

Shanghai Kai Kai Industry

SHSE:600272

CN¥3.0b

Price History & Performance

Summary of share price highs, lows and changes for Anhui Sunhere Pharmaceutical ExcipientsLtd
Historical stock prices
Current Share PriceCN¥12.48
52 Week HighCN¥15.40
52 Week LowCN¥9.92
Beta0.29
1 Month Change1.38%
3 Month Change15.66%
1 Year Change-8.84%
3 Year Change-22.74%
5 Year Change38.03%
Change since IPO193.75%

Recent News & Updates

Anhui Sunhere Pharmaceutical ExcipientsLtd's (SZSE:300452) Earnings Are Weaker Than They Seem

Sep 03
Anhui Sunhere Pharmaceutical ExcipientsLtd's (SZSE:300452) Earnings Are Weaker Than They Seem

Recent updates

Anhui Sunhere Pharmaceutical ExcipientsLtd's (SZSE:300452) Earnings Are Weaker Than They Seem

Sep 03
Anhui Sunhere Pharmaceutical ExcipientsLtd's (SZSE:300452) Earnings Are Weaker Than They Seem

Anhui Sunhere Pharmaceutical ExcipientsLtd (SZSE:300452) Has Affirmed Its Dividend Of CN¥0.25

May 26
Anhui Sunhere Pharmaceutical ExcipientsLtd (SZSE:300452) Has Affirmed Its Dividend Of CN¥0.25

Shareholder Returns

300452CN PharmaceuticalsCN Market
7D-2.5%-3.1%-2.1%
1Y-8.8%-4.4%9.8%

Return vs Industry: 300452 underperformed the CN Pharmaceuticals industry which returned -4.4% over the past year.

Return vs Market: 300452 underperformed the CN Market which returned 9.8% over the past year.

Price Volatility

Is 300452's price volatile compared to industry and market?
300452 volatility
300452 Average Weekly Movement6.7%
Pharmaceuticals Industry Average Movement7.4%
Market Average Movement8.8%
10% most volatile stocks in CN Market13.0%
10% least volatile stocks in CN Market5.8%

Stable Share Price: 300452 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 300452's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001969Zheng Long Yinwww.shanhe01.com

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. research and development, production, and sale of new pharmaceutical excipients in China. The company provides cellulose, starch, povidone, stearic acid, coating powder, resin, food additive, and other products.

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Fundamentals Summary

How do Anhui Sunhere Pharmaceutical ExcipientsLtd's earnings and revenue compare to its market cap?
300452 fundamental statistics
Market capCN¥2.89b
Earnings (TTM)CN¥160.43m
Revenue (TTM)CN¥843.26m

18.1x

P/E Ratio

3.4x

P/S Ratio

Is 300452 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300452 income statement (TTM)
RevenueCN¥843.26m
Cost of RevenueCN¥572.25m
Gross ProfitCN¥271.01m
Other ExpensesCN¥110.58m
EarningsCN¥160.43m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.69
Gross Margin32.14%
Net Profit Margin19.03%
Debt/Equity Ratio32.4%

How did 300452 perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

36%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 12:53
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shuchang LiuChangjiang Securities Co. LTD.
Tan Huan GanCitic Securities Co., Ltd.
Shitong HanCitic Securities Co., Ltd.